Background: Breast cancer is the most common type of cancer in women worldwide. Mammography is considered the "gold standard" in the evaluation of the breast from an imaging perspective. Apart from mammography, ultrasound examination and magnetic resonance imaging are being off ered as adjuncts to the preoperative workup. Recently, other new modalities like positron emission tomography, 99mTc-sestamibi scintimammography, and electrical impedance tomography (EIT) are also being off ered. However, there is still controversy over the most appropriate use of these new modalities. Based on the literature, this review evaluates the role of various modalities used in the screening and diagnosis of breast cancer.
INTRODUCTION
Breast cancer is the second leading cause of cancer deaths in women today (after lung cancer) and the most common cancer in women. Its incidence increases dramatically with age. Although most breast cancers occur in women older than 50 years, 31 percent of women diagnosed with breast cancer between 1996 and 2000 were younger than 50 years 1 . The rate of increase is greatest in women younger than 50 years but most cases (approximately 80 % of invasive cases) occur after age 50 years. Breast cancer commonly affects women older than 40 years of age; however, younger women can also be affected, especially those with a genetic predisposition 1, 2 . Important risk factors for female breast cancer include an early age at the onset of menarche, late age of menopause, a fi rst full-term pregnancy after the age of 30 years, a history of pre-menopausal breast cancer in mother or sister, and personal history of breast cancer or sometimes even benign proliferative breast disease. Obesity, nulliparity, and urban residence have also been associated with an increased risk of breast cancer.
The earliest sign of breast cancer is an abnormality depicted on a mammogram, before the woman or her physician can feel it. When breast cancer has grown to the point where physical signs and symptoms appear, the patient feels a breast lump (usually painless) 3 . Other presentations include tenderness, skin irritation or dimpling, and nipple discharge or pain, scaliness, ulceration, or retraction. Breast pain is commonly due to benign conditions and not usually the fi rst symptom of breast cancer 3 . Breast masses have a varied etiology, benign and malignant. Fibroadenoma is the most common benign breast mass and invasive ductal carcinoma is the most common malignancy. Effi cient and accurate evaluation can maximize cancer detection and minimize unnecessary testing and procedures 4 .
INITIAL EVALUATION

History
A thorough patient history is necessary for the physician to identify risk factors for breast cancer. Some risk . (Table 1) With the patient supine and one arm raised, the physician thoroughly palpates breast tissue on the raised-arm side in the superfi cial, intermediate, and deep tissue planes (i.e. the "triple touch" technique); axilla, supraclavicular area, neck, and chest wall, assessing the size, texture, and location of any masses 9 . The physician should note the size of the masses to document changes over time. Next, the physician should inspect the areola-nipple complex for any discharge. CBE sensitivity can be improved by longer duration (i.e. fi ve to 10 minutes) and increased precision (i.e. using a systematic pattern, varying palpation pressure, and using three fi nger pads and circular motions) 10 . (Table 2 ) Benign masses generally cause no skin change and are smooth, soft to fi rm, and mobile, with well-defined margins. Diffuse, symmetric thickening, which is common in the upper outer quadrants, may indicate fi brocystic changes. Malignant masses generally are hard, immobile, and fi xed to surrounding skin and soft tissue, with poorly defi ned or irregular margins 10 . However, mobile or nonfi xed masses can be cancerous. Infections such as mastitis and cellulitis tend to be erythematous, tender, and warm to the touch. They may be more circumscribed if an abscess has formed. Similar symptoms may occur in patients with infl ammatory breast cancer. Therefore, caution should be used in assessing patients with suspected breast infections.
IMAGING METHODS
Mammography
Mammography is the primary imaging modality for breast cancer screening and diagnosis. Mammography is X-ray imaging of the breasts designed to detect tumours or other abnormalities. Improvements over the last decade in the quality of performance and the reporting of mammography studies are the most important advances in breast imaging 11 . With digital mammography, an image of the breast is recorded electronically rather than on fi lm. The acquired digital image can be stored in computer memory and printed out later as a fi lm or displayed and interpreted on a high-defi nition monitor. The ability to alter contrast and brightness permits further evaluation of abnormal areas to identify features diagnostic of benign and malignant disease [12] [13] [14] . Although the overall cancer-detection rate is similar in screen-fi eld and full-fi eld mammography, screenfi eld imaging has better image quality and fewer artefacts, and requires fewer patient recalls 14 . In addition to its usefulness in telemammography, digital mammography may be more accurate than traditional mammography. Studies comparing the methods are underway. Potential new techniques include threedimensional imaging, lower-dose radiation, dual energy subtraction, contrast-enhancement imaging and computerassisted diagnosis 15 . A standardized BI-RADS mammography report should include the reason(s) for doing the examination, the observed composition of the breast tissue, a description of the mammographic fi ndings using the standardized lexicon, and a fi nal assessment with management recommendation 16 . The overall density of a patient's breast tissue will help determine the sensitivity of mammography. Since breast cancers are radiodense (e.g. white on mammograms), radiolucent fat (dark grey-to-black on mammograms) provides an excellent background on which to see small cancers. On the other hand, dense fi broglandular breast tissue can obscure small cancers. Therefore, the standardized mammography report must include a statement about the overall composition of the breast in terms of the relative amounts of fatty and dense tissue. The breast composition can be characterized as one of four types: (1) the breast is almost entirely fatty (2) there are scattered islands of fi broglandular tissue ( Fig. 1) , (3) the breast tissue is heterogeneously dense (which may lower the sensitivity of mammography) and (4) the breast tissue is extremely dense (Fig. 2 ) (which will always lower the sensitivity of mammography). The standard lexicon for reporting abnormal fi ndings on mammograms includes descriptors to indicate the likelihood of malignancy. Masses and calcifi cations are the most common abnormalities encountered on mammograms, and the radiographic appearances of these abnormalities are important clues to their etiology 17, 18 . The standardized report will also include one of six assessment categories, indicating the likelihood of malignancy and the radiologist's recommendations for management (Table 3 ) Category "0", or "Incomplete: Need additional imaging evaluation," is usually used for a screening examination in which a defi nitive recommendation cannot be made until more information is obtained. The additional information that is needed might be an earlier comparison mammogram or a subsequent study, such as a problem-solving (diagnostic) mammogram or ultrasonogram. Once the individual patient work-up has been completed, the resulting examination will then be assigned to one of fi ve other assessment categories as listed in Table 3 .
Screening mammography: Screening mammography is used to detect breast changes in women who have no signs or symptoms or observable breast abnormalities. The goal is to detect cancer before any clinical signs are noticeable. This usually requires at least two mammograms from different angles of each breast. The role of various modalities in breast imaging 
Negative
There is nothing to comment on.
2
Benign fi nding A defi nitely benign fi nding described.
3
Probably benign fi nding Very high probability of being benign. Short-term follow-up recommends establishing stability.
4
Suspicious abnormality Not characteristic, but has reasonable probability of being malignant. Biopsy should be considered.
5
Highly suggestive of malignancy High probability of being cancer. Malignancy Appropriate action should be taken. Diagnostic mammography: Diagnostic mammography can help physicians determine whether a lesion is potentially malignant, and it also screens for occult disease in surrounding tissue. Diagnostic mammography is used to investigate suspicious breast changes such as a breast lump, breast pain, an unusual skin appearance and nipple thickening or nipple discharge 18 . It is also used to evaluate abnormal fi ndings on a screening mammogram. Additional images can be made from other angles or focus on areas of concern at higher magnifi cation.
Ultrasonography
Ultrasonography is the most important adjunctive imaging modality for breast cancer diagnosis. Over the years, it has also undergone signifi cant improvements that have extended its utility for breast imaging. The traditional role of ultrasonography was to diff erentiate cysts from solid masses 19, 20 . Two of the most important clinical advances in breast US have been the development of criteria that allow improved benign/malignant diff erentiation of solid breast lesions and the use of US to guide interventional procedures such as needle aspirations, core-needle biopsies, and pre-biopsy needle localizations of breast masses or calcifi cations 21, 22 . Ease of use and real-time imaging capability make breast ultrasound a method of choice for guiding breast biopsies and other interventional procedures. Frequent advances in transducer design, electronics, computers, and signal processing have improved the quality of ultrasound images to the extent that sonography is now a major mode of imaging for the clinical diagnosis of breast cancer. Breast ultrasound is routinely used for diff erentiating cysts and solid nodules with high specificity. In combination with mammography, ultrasound is used to characterize solid masses as benign or malignant. Characteristic ultrasonographic features of a cyst are its round or oval shape, circumscribed margins, anechoic interior, and enhanced distal echoes posterior to the cyst (FIG-3) . Continuing improvements in ultrasonography The role of various modalities in breast imaging equipment have led to the identifi cation of additional features that may help to diff erentiate benign from malignant solid masses 23 . These include the shape, margins, and echogenicity of a breast mass (Fig. 4) . It remains to be seen whether these signs are reliable enough to avoid the need for biopsy of solid masses that have "benign" ultrasound features. Ultrasonography can eff ectively distinguish solid masses from cysts, which account for approximately 25 percent of breast lesions 24, 25 . When strict criteria for cyst diagnosis are met, ultrasonography has a sensitivity of 89 percent and a specifi city of 78 percent in detecting abnormalities in symptomatic women 18 . Recurrent or complex cysts may signal malignancy; therefore, further evaluation of these lesions is required 26. Although ultrasonography is not considered a screening test, it is more sensitive than mammography in detecting lesions in women with dense breast tissue 25, 26. It is useful in discriminating between benign and malignant solid masses 25, 26, and it is superior to mammography in diagnosing clinically benign palpable masses (i.e. up to 97 percent accuracy versus 87 percent for mammography) (ref. 26) . Ultrasound can be used in younger women and women with breast implants but cannot always detect micro calcifi cations. It is entirely a safe method, and can be used regularly for these purposes. The eff ectiveness depends on the ability of the radiologist performing the test. Another disadvantage is that it cannot diff erentiate between certain solid masses and it has poor ability to visualise deep lesions. Breast ultrasound is used in many forms. B-mode is the most common form of imaging for the breast, although compound imaging and harmonic imaging are being increasingly applied to better visualize breast lesions and to reduce image artefacts. These developments, together with the formulation of a standardized lexicon of solid mass features, have improved the diagnostic performance of breast ultrasound 26, 27 . Doppler ultrasound During a breast ultrasound examination the sonographer or physician performing the test may use Doppler techniques to evaluate blood fl ow or lack of fl ow in any breast mass. With the development of ever more sensitive color doppler and power Doppler ultrasound machines the ability to detect fl ow in solid masses and even to diff erentiate that fl ow also has added another level of sophisication to ultrasound analysis of breast masses. Color doppler does not discriminate completely between benign and malignant masses; the presence of signals in a lesion that is otherwise thought to be benign should prompt a biopsy while the absence of signals in an indeterminate lesion is reassuring. Therefore color doppler is now widely established as a useful addition to breast imaging and dynamic features of ultrasound that are useful in breast diagnosis 27 .
Magnetic resonance imaging
Magnetic resonance imaging (MRI) is a non-invasive, usually painless medical test that helps physicians diagnose and treat medical conditions. MRI does not use ionising radiation (x-rays). MRI of the breast off ers valuable information about breast conditions that cannot be obtained by other imaging modalities, such as mammography or ultrasound. MRI of the breast is not a replacement for mammography or ultrasound imaging but rather a supplemental tool for detecting and staging breast cancer and other breast abnormalities 28 .
Fig. 3. Ultrasonogram of carcinoma. This mass (arrows)
has features suggesting malignancy: ill-defi ned margins, height equal to or greater than width, and low-level heterogeneous internal echoes. Medical studies are currently being conducted to determine whether MRI can contribute to the early detection and prevention of deaths from breast cancer. New pulse sequences in MRI combined with contrast enhancement kinetic perfusion curves have greatly enhanced detection of mammographically occult cancers. Magnetic resonance imaging (MRI) is being studied to determine its usefulness in diagnosing breast masses. Gadolinium contrast is used to enhance the vascularity of malignant lesions. Although MRI is highly sensitive (85 to 100 percent), it lacks specifi city (47 to 67 percent) (ref. 28, 29 ) . MRI is inferior to mammography in detecting in situ cancers and cancers smaller than 3 mm, and it provide no cost benefi t over excisional biopsy for verifying malignancy 28, 29 . Research suggests two potential roles for MRI in breast mass diagnosis: evaluating patients with silicone breast implants and assessing patients in whom evaluation by ultrasonography and mammography is problematic 30 . The latter group includes patients who have had breast-conserving surgery; patients with known carcinoma in whom multifocal, ipsilateral, or contralateral disease must be ruled out, patients with axillary metastasis and an unknown primary, patients with extensive postoperative scarring, and patients with extremely dense parenchyma [30] [31] [32] . Although MRI improves detection of early breast cancers in carriers of BRCA mutations, it has a lower specifi city than mammography, which requires additional evaluations. It also has limited sensitivity in detecting ductal carcinoma in situ. MRI of the breast cannot always distinguish between cancer and benign breast disease (such as fi broadenomas), leading to a false positive result 31 . A benefi t of MRI is that it can easily acquire direct views of the breast in any orientation while mammography requires re-orientation of the breast and mammography system for each view desired. An MRI exam of the breast typically takes between 30 and 60 minutes. The injection of a contrast agent can further the ability of MRI to detect a specifi c feature or in case of dynamic contrastenhancement MRI study, the functionality of tissue 32 . The contrast agents used are paramagnetic agents with gadolinium (Gd-DTPA) being the most common. The eff ect of this agent is to shorten the relaxation time of local spins causing a decrease in signal in T2 weighted images and an increase in T1 weighted images. The increased vascularity of tumours produces a preferential uptake of contrast agent and the technique can be used to improve their contrast from surrounding normal tissue 32, 33 . Furthermore if MRI scans are repeatedly acquired following the contrast injection, the dynamic nature of contrast uptake can be examined, which may improve the diff erentiation of benign and malignant disease. This is called dynamic contrast-enhancement MRI 34 . A few advantages of MRI of the breast are that it can be used in women with denser breasts, it is non-ionising, it can take images in any orientation, it can determine multi-focal cancers and it is useful in determining if the cancer has spread to the chest wall. It can also be used to check for recurrence of cancer in women who have undergone lumpectomy. MRI can assess if a newly inverted nipple is a sign of retroareolar cancer, it can see breast implants and look for ruptures. The disadvantages are that it is expensive, requires injection of a contrast agent for functional imaging. Specifi city can be limited, it is highly sensitive to small abnormalities, and cannot image calcifi cations and can induce feelings of claustrophobia. It has long scan times in comparison to x-ray mammography 35 .
Positron emission tomography (PET)
Positron emission tomography (PET scan) is one of the newest forms of imaging tests. PET is a type of nuclear medicine study. A tiny amount of radioactive substance is injected into an arm vein. This substance gives off small amount of radiation that is detected by a special PET scanner to form an image. The most commonly used substance in this test is fl uorodeoxyglucose (FDG), which is a type of sugar. It is an eff ective means of predicting response to neoadjuvant chemotherapy in patients with breast cancer 36 . It goes to places in the body where the cells are most active, especially highlighting cancerous tissue and ensure that the most appropriate form of treatment is selected 36 . A PET scan may be combined with computed tomography (CT) to provide both an anatomical and functional view of the suspect cells. With all this information, doctors can better diff erentiate between healthy and cancerous cells, even when the cancer is too small to detect by conventional imaging. This is particularly important when looking to see if cancer has spread ("metastasized") from the breast to other parts of the body 37 . PET is being used to detect metastatic disease (cancer spread) and has been successful in that role. The PET scan is not currently used for primary breast cancer detection because it does not reliably detect tumors smaller than 5-10 mm, but research is being done to improve the accuracy of this test.
Electrical impedance tomography (EIT)
EIT is a relatively new imaging method that has evolved over the past 20 years. It has the potential to be of great value in clinical diagnosis; however, EIT is a technically diffi cult problem to solve in terms of developing hardware for data capture and the algorithms to reconstruct the images 38 . "Electrical Impedance Computerized Mammograph MEIK" is an EIT system for breast diagnostics approved for clinical usage in Russia. The system realizes 3D imaging approach using fl at matrix with 256 electrodes. An EIT system utilizes an array of electrodes to apply currents to an imaging domain and measures the resulting voltages on the periphery 38 . The measurement results are then input to a reconstruction algorithm to produce an image of the impedance distribution inside the domain. Electrical impedance imaging scans the breast for electrical conductivity based on the idea that breast cancer cells conduct electricity better. It involves passing a very small electrical current through the body and detecting it on the skin of the breast with a small probe. The test does not use radiation and does not require breast compression. This test has received approval by the US Food and Drug Administration to be used as a diagnostic aid to mammography 39 
. However, it has not undergone The role of various modalities in breast imaging
enough clinical testing to recommend its use in breast cancer screening. Some evidence has been found that malignant breast tumours have lower electrical impedance than surrounding normal tissues. Although the separation of malignant tumours from benign lesions based on impedance measurements needs further investigation, electrical impedance could be used as an indicator for breast cancer detection. The conductivity and resistance of breast tumours are known to diff er signifi cantly from those of normal breast tissues; EIT is being studied as a modality for breast cancer imaging to exploit these diff erences. EIT and T-scan Electrical Impedance imaging is based on the idea that tissues have diff erent conductivities depending on their cell structure and pathology 39 . Cancerous tissue causes alterations in the intracellular and extra cellular fl uid compartments, cell membrane surface area, ionic permeability, and membrane associated water layers. These histological biochemical changes within the cancerous tissue give rise to measurable changes in tissue electrical impedance 39, 40 . When a small alternating current is placed across the breast, the increase in electrical conductance and capacitance of the cancer tissue distorts the electric fi eld within the breast and the resulting impedance map can be used to highlight a malignant area. Among non-invasive imaging techniques, EIT is a technique off ering low cost, but low resolution, images. Inaccurate modelling of the regionally varying electrode-skin contact impedance and poor signal-to-noise ratio causes its main limitation. At present, X-ray mammography is the primary standard imaging modality used for breast cancer screening in clinical practice, so it is desirable to study EIT in the geometry of mammography.
Thermography
Thermography is based on the principle that metabolism and blood vessel proliferation in both pre-cancerous tissue and the area surrounding a developing breast cancer is almost always higher than in normal breast tissue. Developing tumours increase circulation to their cells by enlarging existing blood vessels and creating new ones in a process called vascularisation. This process frequently results in an increase in regional surface temperatures of the breast. Thermography uses ultra-sensitive infrared cameras and PCs to generate high-resolution diagnostic images of these temperature variations 41 . Although thermography is an appealing method of screening for breast cancer, research over the past 20 years has failed to produce a system that is reliable for such a purpose and so thermography is not widely used 41 . It should also be noted that attenuation of infrared radiation in tissue is high. For this reason, thermography will only ever be able to provide information on the surface temperature variations and so no depth information will be available. This is a severe limitation of thermography in detecting breast cancer.
Galactography
In this x-ray procedure, the milk duct may be dilated and a fi ne plastic tube is placed into the opening of the duct in the nipple. A small amount of contrast medium is injected, which outlines the shape of the duct on an x-ray image and shows whether a mass is present inside the duct. While mammography and MRI are excellent ways to image the breast, they cannot visualize inside the breast's milk ducts. A ductogram or galactogram is sometimes helpful for determining the cause of nipple discharge. The most common use of galactography is to evaluate a woman who has a bloody or clear discharge from her breast nipple and an otherwise normal mammogram. The procedure normally takes between 30 minutes and an hour. The dilation of the milk duct can sometimes be uncomfortable; however it is usually not painful. The nipple may be squeezed to identify the milk duct with the discharge. The advantage of galactography is that it can fi nd small cancerous and non-cancerous tumors that cannot be identifi ed in any other way so that they may be removed at an early stage. The limitation of ductography is that, if there is no discharge at the time of the exam, the duct cannot be identifi ed, so the test cannot be performed. In addition, some ducts are quite small and cannot be dilated. If the incorrect duct is injected, a wrong diagnosis can be made.
Technetium sestamibi scan (scintimammography)
A compound known as technetium sestamibi has been studied to help detect breast cancer. This test is marketed under the trade name Miraluma. In this procedure, a small amount of the radioactive substance is injected into an arm vein. A special camera then records where radiation has accumulated in the breasts. This procedure cannot distinguish cancer from noncancerous lesions as accurately as routine mammography, and is not used as an initial screening test. Some radiologists believe it is sometimes useful in looking at suspicious areas found by regular mammograms. However, studies of the test have yielded varying results. The general consensus is that this test is less sensitive than mammography, especially when the tumour is still small and most likely to be curable. For these reasons, the exact role of this test remains unclear 42 . Current research is aimed at improving the technology and evaluating its use in specifi c situations such as in the dense breasts of younger women. Nuclear medicine breast imaging or scintimammography is sometimes used alongside x-ray mammography in the diagnosis of breast disease as it has the ability to determine if a located lesion is malignant. This investigation of the breast usually takes between 45 and 60 minutes. To perform an exam the radioactive tracer (Tc-99m sestamibi) is injected into the patients arm. The patient is then asked to lie face down on a special table and suspend her breast through a hole. Approximately fi ve minutes after the injection, images of the breast are taken from several angles using a gamma camera. A few advantages of this method are that it can be used on patients with dense breasts. It can image large palpable lesions that do not appear using other imaging modalities whilst it is 90 % accurate for abnormalities over 1cm it is only 40-60 % accurate for smaller abnormalities. It can be used to test tissue remaining from mastec-tomy, it can be used to check for metastases in the axillary lymph nodes and it is able to determine multifocal breast cancers 43 . Disadvantages are that it involves injecting a substance into a patient. It is invasive and long examination time.
Computed tomography
Spiral CT is useful for elucidating problems in the diagnosis of breast lesions. Its advantages consist in the speed of the method, comfort for the patient, absence of movement artefacts, easy standardization and wide applicability. Dynamic contrast-enhanced CT of the breast has been found to be eff ective for the detection of intraductal extension of breast carcinoma and is thought to be useful in the preoperative assessment of indications of breast-conserving surgery 44 . The lesions appear attenuating compared with fatty background, and they show early enhancement on arterial phase on dynamic contrast-enhanced CT. CT is usually not the fi rst modality to be used in imaging breast cancer, but it may be used as an adjuvant for monitoring spread. Although it involves some exposure to radiation, it should be considered in patients in whom MRI is contraindicated. Three-dimensional (3D) helical CT can provide good information about the spread of breast cancer and could be an alternative to 3D MRI for preoperative examination of breast cancer 44 . In vitro high-resolution helical CT can depict the internal structure of small nodes. Morphologic changes detected on helical CT help distinguish benign from malignant nodes. Tumours appear as dense lesions on CT and usually shows early contrast enhancement similar to that seen with dynamic MRI. CT is less sensitive than mammography for detecting microcalcifi cation when it is the sole manifestation of early cancer 45 .
INTERVENTIONAL METHODS
A suspicious area in the breast may be detected by physical exam, mammogram or another imaging method or by some combination of these modalities. But regardless of the method of detection, the presence of cancer can only be confi rmed by a biopsy, in which a sample of cells or tissue is removed and looked at under the microscope. For suspicious areas that cannot be felt, imaging tests may be done to ensure the right area is biopsied. A breast biopsy helps identify any abnormalities in the cells that make up breast lumps or other unusual breast changes, and it can help determine whether or not a surgery is needed or any other treatment.
Open Surgical Biopsy
Open surgical biopsy was a traditional standard method of breast biopsy. For years, excisional biopsy was a woman's only option. Surgical biopsy requires 1.5 to 2.0 inch incision (approximately 3.8 cms to 5.1 cms) in the breast. It may leave a scar at the incision site. However today, many patients are candidates for less invasive biopsy procedures such as vacuum assisted biopsy (Mammotome) or core needle biopsy.
Wire localization
Wire localization is a procedure used to guide a surgical (excisional) breast biopsy of a small mass that would be hard for the surgeon to locate. It can also be useful with areas that look suspicious on the x-ray (due to calcifi cations, for example) but do not have a distinct lump. After numbing the area with local anaesthetic, hollow needles thinner than that used for drawing blood, are inserted into the breast and x-rays are used to guide the needle to the suspicious area. A thin wire is then inserted through the center of the needle. A small hook at the end of the wire keeps it in place. The hollow needle is then removed. The surgeon uses the wire as a guide to locate the abnormal area to be removed.
Needle Biopsy
Many suspicious breast abnormalities can now be diagnosed without surgery by using needle biopsy. There are 2 types of needle biopsies:
Fine needle aspiration (FNA) -FNA biopsy uses a very thin, hollow needle to remove fl uid and tiny fragments of tissue. This procedure involves inserting a thin needle into the breast to remove cells from a lump. These cells are then examined under a microscope. Local anesthesia may be given. This test may be done to determine whether a lump is solid or is a fl uid-fi lled cyst. A cyst will collapse and disappear after the fl uid is removed. If the lump is not a cyst, another type of biopsy may be done.
Core needle biopsy (CNB) -A core needle biopsy is a percutaneous procedure that involves removing small samples of breast tissue using a hollow "core" needle. For palpable lesions, this is accomplished by fi xing the lesion with one hand and performing a free hand needle biopsy with the other. In the case of non-palpable lesions, stereotactic mammography or ultrasound image guidance is used. Stereotactic mammography involves using computers to pinpoint the exact location of a breast mass based on mammograms taken from two diff erent angles. The computer coordinates will help the physician to guide the needle to the correct area in the breast. With ultrasound, the radiologist or surgeon will watch the needle on the ultrasound monitor to help guide it to the area of concern. The needle used during core needle biopsy is larger than the needle used with FNA (usually a 16, 14, or 11 gauge needle is used with the core needle biopsy procedure). The core needle biopsy needle also has a special cutting edge. Core needle biopsy usually allows for a more accurate assessment of a breast mass than FNA (if the sample is found to be solid or cloudy, suspicious-looking fl uid) because the larger core needle usually removes enough tissue for the pathologist to evaluate abnormal cells in relation to the surrounding small sample of breast tissue taken in the specimen. Nevertheless, core needle biopsy like FNA, only removes samples of a mass and not the entire area of concern. Therefore, it is possible that a more serious diagnosis may be missed by limiting the sampling of a lesion (abnormality). A relatively new biopsy procedure called vacuum assisted breast biopsy is able to remove approximately twice the amount of breast tissue compared 217
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with core needle biopsy while still off ering the patient a minimally invasive breast biopsy procedure.
Stereotactic vacuum assisted biopsy
The relatively new vacuum-assisted breast biopsy is a percutaneous procedure that relies on stereotactic mammography or ultrasound imaging. Stereotactic mammography involves using computers to pinpoint the exact location of a breast mass based on mammograms taken from two diff erent angles. The computer coordinates will help the physician to guide the needle to the correct area in the breast. With ultrasound, the radiologist or surgeon will watch the needle on the ultrasound monitor to help guide it to the area of concern. The patient will either by positioned in the upright or prone (face down) position for a vacuum-assisted biopsy. Vacuum-assisted biopsy is a minimally invasive procedure that allows for the removal of multiple tissue samples. However, unlike core needle biopsy, which involves several separate needle insertions to acquire multiple samples, the special biopsy probe used during vacuum-assisted biopsy is inserted only once into the breast through a small skin nick made in the skin of the patient's breast. Two new stereotactic biopsy methods can remove more tissue than a core biopsy.
The Mammotome (brand name)
It is also known as vacuum-assisted biopsy. For this procedure the skin is numbed and a small incision (about Ľ inch) is made. A probe is inserted through the incision into the abnormal area of breast tissue. A cylinder of tissue is suctioned into the probe then a rotating knife within the probe cuts the tissue sample from the rest of the breast 46 . The Mammotome procedure is done as an outpatient. No stitches are needed and there is minimal scarring. This method usually removes about twice as much tissue as core biopsies.
The ABBI method (ABBI also known as large core biopsy is a brand name that stands for Advanced Breast Biopsy Instrumentation).
It is a surgical technique that involves removing an entire intact breast lesion under image guidance. While the ABBI procedure tends to be less invasive than the traditional open surgical biopsy, this technique has not gained widespread acceptance. It uses a probe with a rotating circular knife and thin heated electrical wire to remove a large cylinder of abnormal tissue 47 . In some centres, the biopsy is guided by an MRI, which locates the tumours, plots its co-ordinates, and aims the stereotactic biopsy device into the tumour. ABBI requires the removal of a signifi cant portion of normal breast tissue just to reach the lesion. Critics of large core biopsy (ABBI) say that the procedure removes unnecessary normal breast tissue and does not remove an adequate margin of tissue around the breast lesion for laboratory analysis. For these reasons, large core biopsy (ABBI) is not widely embraced in the medical community. Vacuum-assisted biopsy may be a viable alternative to large core biopsy (ABBI) in some instances.
CONCLUSION
The literature shows that the only radiological technique that has had signifi cant impact on the diagnosis, staging and patient follow-up in the case of screening asymptomatic breasts for cancer is low-dose mammography. Mammography is the only reliable screening test proven in breast imaging. Although it is an eff ective screening tool, it does have limitations, particularly in women with dense breasts. Recent studies show that Computer aided detection, breast ultrasound and breast magnetic resonance imaging (MRI) are frequently used adjuncts to mammography in today's clinical practice and these techniques enhance the radiologist's ability to detect cancer and assess disease extent, which is crucial in treatment planning and staging.
Positron emission tomography (PET) also plays an important role in staging breast cancer and monitoring treatment response. As imaging techniques improve, the role of imaging will continue to evolve with the goal remaining a decrease in breast cancer morbidity and mortality. The progress in the development and commercialisation of EIT breast imaging system will defi nitely help to promote other systems and applications based on the EIT and similar visualization methods.
At present x-ray mammography is the most commonly used breast-imaging technique and is thus the "gold standard" in the evaluation of the breast from an imaging perspective.
